Skip to main content
OpenTrials
Completed

NCT Number: NCT03301077

Mental Health in Austrian Teenagers (MHAT)

The purpose of the Mental Health in Austrian Teenagers (MHAT) - Study is to collect the first epidemiological data on mental health and psychiatric disorders in a representative sample of Austrian adolescents between 10 and 18 years.

Completed

Looking for future studies?

Notify Me

Key information

Age range

10 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical University of Vienna, Dep. of Child and Adolescent Psychiatry

Vienna, 1090, Austria

About this study

Knowing about the prevalence of psychiatric disorders and related risk and protective factors is essential for the development of prevention programs and therapeutic approaches. Up to now, no epidemiological data on prevalence rates of psychiatric disorders and related risk and protective factors based on a representative sample is available for Austrian adolescents.

The aim of the study is to present rates of behavioral, emotional and social problems as well as prevalence rates of mental disorders. Furthermore the investigators want to examine risk factors, protective factors and quality of life in a large sample of adolescents aged 10 to 18 years. A two step design is chosen for this purpose to obtain diagnoses based on the Diagnostic and Statistical Manual of the American Psychiatric Association, Version 5 (DSM-5):

  • Phase 1 (screening) is a screening for emotional, behavioral and social problems as well as social and demographic correlates, risk and protective factors and quality of life.
  • Phase 2 (interviews) includes structured diagnostic interviews to assess psychiatric diagnoses according to DSM-5 criteria with adolescents above a predefined cut-off score in the screening, and a random sample of adolescents scoring below the cut-off.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adolescents aged 10-18

Exclusion criteria

  • no written informed consent possible due to intelligence or no willingness by parents to include minor

Treatment and study plan

2-phase epidemiological study (screening, interviews)

Other

first phase is the screening phase, second phase is the interview phase

Primary outcomes

  1. psychiatric problems (diagnoses based on the Diagnostic and Statistical Manual of the American Psychiatric Association, Version 5 (DSM-5)

    Time frame: 12 months

    Screening and interview

Secondary outcomes

  1. rates of behavioral, emotional and social problems (representation of data collected at interview)

    Time frame: 12 months

    YSR (Youth Self Report) questionnaire

  2. psychiatric disorder related risks and protective factors (representation of data collected at interviews)

    Time frame: 12 months

    Kinder-DIPS (Diagnostisches Interview psychischer Störungen) interview

  3. quality of life (total score, self-perception, parent relation & home life, social support & peers, school environment and bullying)

    Time frame: 12 months

    KIDSCREEN (Kidscreen) questionnaire

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Collaborators

  • Ludwig Boltzmann Institut Health Promotion Research
  • Pharmig - Gesundheitsziele aus dem Rahmen-Pharmavertrag

Registry information

Official study title

The Mental Health in Austrian Teenagers (MHAT) - Study: First Epidemiological Survey

Acronym: MHAT

Important dates

Study start
2013
Primary completion
2015
Study completion
2015
First posted
Oct 4, 2017
Registry last updated
Mar 7, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.